
Articles
-
1 month ago |
jwatch.org | Paul Mueller
-
Jan 14, 2025 |
jwatch.org | Paul Mueller
Paul S. Mueller, MD, MPH, FACP, reviewing Lithium, in the blood-concentration therapeutic range, is associated with excess risk for developing stage ≥3 CKD. Lithium is a mainstay treatment for people with bipolar disorders, and it augments antidepressant drug therapy for unipolar depression. However, lithium use is associated with excess incidence of chronic kidney disease (CKD).
-
Nov 20, 2024 |
jwatch.org | Paul Mueller
-
Oct 22, 2024 |
jwatch.org | Paul Mueller
-
Aug 13, 2024 |
jwatch.org | Paul Mueller
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →